Unbiased AI-powered news
Japanese researchers have launched a randomized clinical trial of decellularized cow-tendon material for anterior cruciate ligament reconstruction. The study compares the material to patients' own tendons in 57 participants across six sites. Safety was previously confirmed in seven patients.
Japan TimesJapanese researchers have begun a clinical trial of a medical material derived from cow tendons for anterior cruciate ligament reconstruction. The work is led by Kiyotaka Iwasaki, a professor at Waseda University, together with researchers from Tokyo Women’s Medical University.
They confirmed safety of the material in surgeries on seven patients before starting the randomized controlled study at six institutions across Japan.
The trial assigns 57 patients needing ACL reconstruction to either the experimental cow-derived material or a transplant of their own tendons taken from other areas. Standard treatment currently uses tendons from the patient’s hamstring or knee. Removal of those tendons can cause pain at the harvest site and may reduce muscle strength.
Cow tendons offer suitable thickness and strength, but untreated tissue can provoke immune reactions such as inflammation. The researchers apply a decellularization process that uses a pulsating pump to circulate a cell-breaking solution deep into the tissue while microwaves accelerate removal of cellular components.
The resulting tissue is then freeze-dried and sterilized while retaining mechanical strength.
,” Iwasaki said. ” Iwasaki founded CoreTissue BioEngineering in 2016. The researchers aim to obtain regulatory approval for the device in Japan in 2029 and are preparing a clinical trial in the U.S. In Japan, 20,000 to 30,000 people, typically high-school or college athletes, suffer ACL injuries each year, and about 15,000 undergo reconstruction surgery.
More than 200,000 people are affected annually. One researcher hopes to extend the material to reconstruction of other ligaments in the knee as well as in the ankle and inner elbow.
Single source — no framing comparison available.
The U.S. Supreme Court ruled 7-2 on June 25 that federal pesticide regulations bar state courts from holding Bayer liable for failing to warn that Roundup causes cancer. The decision ends a Missouri case and blocks thousands of similar claims.
The U.S. Supreme Court ruled 7-2 that federal pesticide law blocks state lawsuits claiming Monsanto failed to warn users about cancer risks from Roundup. The decision rests on the EPA's repeated finding that glyphosate is not likely to cause cancer.
The IndependentA 23-year-old British woman faces the death penalty after being charged with killing a 26-year-old British man she met on Facebook. She alleges the act was self-defense following abuse during her second visit to Dubai.